[Guidelines for stage I to III melanoma].

Fiche publication


Date publication

septembre 2016

Journal

Bulletin du cancer

Auteurs

Mots clés

Antineoplastic Agents, therapeutic use, Chemotherapy, Adjuvant, Female, Genotype, Humans, Male, Margins of Excision, Melanoma, classification, Neoplasm Staging, Proto-Oncogene Proteins B-raf, genetics, Sentinel Lymph Node, pathology, Sentinel Lymph Node Biopsy, Skin Neoplasms, classification

Référence

Bull Cancer. 2016 Sep;103(9):743-52